These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11979735)

  • 1. [Anti-Helicobacter pylori effects of Bainiku-ekisu (concentrate of Japanese apricot juice)].
    Fujita K; Hasegawa M; Fujita M; Kobayashi I; Ozasa K; Watanabe Y
    Nihon Shokakibyo Gakkai Zasshi; 2002 Apr; 99(4):379-85. PubMed ID: 11979735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the folk remedy, Bainiku-ekisu, a concentrate of Prunus mume juice, on Helicobacter pylori infection in humans.
    Nakajima S; Fujita K; Inoue Y; Nishio M; Seto Y
    Helicobacter; 2006 Dec; 11(6):589-91. PubMed ID: 17083382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fruit-juice concentrate of Asian plum inhibits growth signals of vascular smooth muscle cells induced by angiotensin II.
    Utsunomiya H; Takekoshi S; Gato N; Utatsu H; Motley ED; Eguchi K; Fitzgerald TG; Mifune M; Frank GD; Eguchi S
    Life Sci; 2002 Dec; 72(6):659-67. PubMed ID: 12467906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the Antibacterial Efficacy of Bainiku-Ekisu against Pathogens.
    Yang DJ; Chen HY; Liu SC
    Int J Bacteriol; 2014; 2014():460395. PubMed ID: 26904733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infused juice concentrate of Japanese plum Prunus mume attenuates inflammatory vascular remodeling in a mouse model of hypertension induced by angiotensin II.
    Okuno K; Torimoto K; Kuroda R; Cicalese SM; Okuno Y; Kono R; Marumoto S; Utsunomiya H; Eguchi S
    Hypertens Res; 2023 Aug; 46(8):1923-1933. PubMed ID: 37308550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa.
    Sanduleanu S; Jonkers D; De Bruine A; Hameeteman W; Stockbrügger RW
    Aliment Pharmacol Ther; 2001 Mar; 15(3):379-88. PubMed ID: 11207513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Helicobacter pylori infection].
    Kubota T; Fujioka T; Nasu M
    Rinsho Byori; 1998 Jul; 46(7):623-8. PubMed ID: 9721527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of different organic acids (citric, malic and ascorbic) on intragastric urease activity.
    Agha A; Opekun AR; Abudayyeh S; Graham DY
    Aliment Pharmacol Ther; 2005 May; 21(9):1145-8. PubMed ID: 15854177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis.
    Sanduleanu S; Jonkers D; De Bruïne A; Hameeteman W; Stockbrügger RW
    Aliment Pharmacol Ther; 2001 Aug; 15(8):1163-75. PubMed ID: 11472319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epinecidin-1 antimicrobial activity: In vitro membrane lysis and In vivo efficacy against Helicobacter pylori infection in a mouse model.
    Narayana JL; Huang HN; Wu CJ; Chen JY
    Biomaterials; 2015 Aug; 61():41-51. PubMed ID: 25996410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activities of peptide Cbf-K
    Jiang M; Ma L; Huang Y; Wu H; Dou J; Zhou C
    Microb Pathog; 2020 Jan; 138():103847. PubMed ID: 31704464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Helicobacter pylori infection on gastric juice pH.
    Furuta T; Baba S; Takashima M; Futami H; Arai H; Kajimura M; Hanai H; Kaneko E
    Scand J Gastroenterol; 1998 Apr; 33(4):357-63. PubMed ID: 9605256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug resistance of Helicobacter pylori strains isolated from patients with inflammation of stomach mucous membrane and peptic ulcer of stomach and duodenum].
    Borysiewicz J; Bolek A; Prazmowska B; Komorowski J; Mikołajska M
    Med Dosw Mikrobiol; 1993; 45(3):339-43. PubMed ID: 8189807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing proton pump inhibitors in
    Ierardi E; Losurdo G; Fortezza RF; Principi M; Barone M; Leo AD
    World J Gastroenterol; 2019 Sep; 25(34):5097-5104. PubMed ID: 31558859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the sensitivity to gastric acid inhibition Helicobacter pylori status-dependent?
    Smout AJ
    Scand J Gastroenterol Suppl; 1998; 225():32-5. PubMed ID: 9515750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. False negative urea breath tests with H2-receptor antagonists: interactions between Helicobacter pylori density and pH.
    Graham DY; Opekun AR; Jogi M; Yamaoka Y; Lu H; Reddy R; El-Zimaity HM
    Helicobacter; 2004 Feb; 9(1):17-27. PubMed ID: 15156900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of high dose vitamin C treatment on Helicobacter pylori infection and total vitamin C concentration in gastric juice.
    Jarosz M; Dzieniszewski J; Dabrowska-Ufniarz E; Wartanowicz M; Ziemlanski S; Reed PI
    Eur J Cancer Prev; 1998 Dec; 7(6):449-54. PubMed ID: 9926292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemotherapeutic effects of H+/K+ inhibitors on Helicobacter pylori infection.
    Logan RP
    Pharmacol Ther; 1996; 69(1):79-83. PubMed ID: 8857304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against Helicobacter pylori and other bacterial infections by garlic.
    Sivam GP
    J Nutr; 2001 Mar; 131(3s):1106S-8S. PubMed ID: 11238826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori.
    Yakoob J; Abbas Z; Usman MW; Awan S; Naz S; Jafri F; Hamid S; Jafri W
    Microb Drug Resist; 2014 Aug; 20(4):305-9. PubMed ID: 23844851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.